Welcome to the August 2013 IEEE Life Sciences Newsletter
This month we bring you several views of technological advances in life science – and a cautionary note about not blindly accepting what our instruments tell us! In our video, William Heetderks of the National Institute of Biomedical Imaging and Bioengineering gives us his views on how technology will improve healthcare delivery in the future. We present two articles on new approaches to using ultrasound – one providing improved imaging, and the other enhancing the efficiency of anticancer drug delivery. And in the Computational Biology Corner we see why measurements may not always provide us with data.
Dr. William J. Heetderks is the Director of Extramural Science Programs at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. The extramural program supports approximately 800 research and training grants at universities and research centers throughout the United States in fields of bioengineering and biomedical imaging. 
Geoffrey Luke is a graduate student in the Department of Electrical Engineering at The University of Texas at Austin. He received a B.S. in Computer Engineering and Mathematics and a M.S. in Electrical Engineering from the University of Wyoming, where he developed a sensor based on the visual system of the common housefly. 
Stanislav Y. Emelianov (B.S. and Ph.D. from The Moscow State University, Russia) is currently a Professor and an Associate Chair for Research in the Department of Biomedical Engineering at The University of Texas at Austin where he directs the Ultrasound Imaging and Therapeutics Research Laboratory. In addition, Dr. Emelianov is an Adjunct Professor of Imaging Physics at The University of Texas M.D. Anderson Cancer Center in Houston. 
Mathukumalli Vidyasagar is the Founding Head of the Bioengineering Department, University of Texas at Dallas. He is a Fellow of the Royal Society, UK. 
Ayache Bouakaz graduated from the University of Sétif, Algeria, from the Department of Electrical Engineering. He obtained his Ph.D. degree in 1996 from the Department of Electrical Engineering at the Institut National des Sciences Appliquées de Lyon (INSA Lyon), France. 
Jean-Michel Escoffre earned his M.Sc. degrees in Vectorology, Gene Therapy, Vaccinology and Cell Biophysics in 2005 and 2006 respectively, at the University Paul Sabatier (Toulouse, France). He obtained his Ph.D. degree in Cell Biophysics in 2010 at the Institute of Pharmacology and Structural Biology (CNRS, UMR 5089) of the University Paul Sabatier.